Chemoinformaics analysis of 3-Isobutylidene-3a,4-dihydrophthalide
| Molecular Weight | 190.242 | nRot | 1 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 12 |
| Exact Molecular Weight | 190.099 | nRing | 2 |
| Solubility: LogS | -4.156 | nHRing | 1 |
| Solubility: LogP | 3.337 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.9791 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.594 |
| Synth | 4.151 |
| Natural Product Likeliness | 2.099 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.462 |
| MDCK | 0.0000228 |
| BBB | 0.983 |
| PPB | 0.8481 |
| VDSS | 0.529 |
| FU | 0.1195 |
| CYP1A2-inh | 0.535 |
| CYP1A2-sub | 0.271 |
| CYP2c19-inh | 0.341 |
| CYP2c19-sub | 0.877 |
| CYP2c9-inh | 0.442 |
| CYP2c9-sub | 0.77 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.515 |
| CYP3a4-inh | 0.276 |
| CYP3a4-sub | 0.334 |
| CL | 4.71 |
| T12 | 0.378 |
| hERG | 0.035 |
| Ames | 0.686 |
| ROA | 0.732 |
| SkinSen | 0.95 |
| Carcinogencity | 0.902 |
| EI | 0.971 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.634137 |